Basit öğe kaydını göster

Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey

dc.contributor.authorgünay, Murat
dc.contributor.authorSalihoglu, Ziya
dc.contributor.authorSirop, Sarkis
dc.contributor.authorYetik, Huseyin
dc.date.accessioned2021-03-02T22:21:19Z
dc.date.available2021-03-02T22:21:19Z
dc.date.issued2015
dc.identifier.citationYetik H., günay M., Sirop S., Salihoglu Z., "Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey", GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.253, sa.10, ss.1677-1683, 2015
dc.identifier.issn0721-832X
dc.identifier.otherav_0c2f2564-f2db-41e7-81ea-5fcf7053dd40
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/13839
dc.identifier.urihttps://doi.org/10.1007/s00417-014-2867-0
dc.description.abstractTo study the efficacy of intravitreal bevacizumab (IVB) injection as a single treatment for retinopathy of prematurity (ROP).
dc.language.isoeng
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectOFTALMOLOJİ
dc.titleIntravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey
dc.typeMakale
dc.relation.journalGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume253
dc.identifier.issue10
dc.identifier.startpage1677
dc.identifier.endpage1683
dc.contributor.firstauthorID56002


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster